The role of novel antihyperglycaemic agents in the treatment of Type 2 diabetes: From glycaemic control to cardiovascular protection
The advent of new antihyperglycaemic drugs has not only brought a greater variety of drugs used to control glycaemia, but has introduced changes in other important aspects of Type 2 diabetes (T2DM) therapy, cardioprotection and renoprotection. All new antihyperglycaemic drugs: sodium glucose co-tran...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | srp |
| Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2020-01-01
|
| Series: | Arhiv za farmaciju |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632004198Q.pdf |